Alibaba—Alibaba and payment processor AUS Merchant Services agreed to pay $600M to settle DOJ claims they enabled illegal pharmaceutical sales
The US Department of Justice announced that Alibaba Group and AUS Merchant Services agreed to pay a combined $600 million ($125M criminal penalty plus $200M forfeiture from Alibaba; $85M penalty plus $190M forfeiture from AUS) to resolve allegations that merchants used Alibaba's messaging tools to conduct roughly 80,000 illegal sales of pharmaceuticals, controlled substances, and counterfeiting equipment between January 2016 and December 2024, with combined gross merchandise value exceeding $200 million. DOJ said Alibaba employees had internally flagged inadequate compliance controls, and the company continued to profit from transaction fees on the illegal sales; AUS was found to have merely reported flagged bad actors rather than systematically restricting them, allowing at least one merchant to continue illegal sales after being flagged. No independent monitor was imposed; both companies agreed to enhanced compliance, reporting, and cooperation obligations. The European Commission separately imposed an additional €550 million fine on Alibaba for related conduct in the EU market.
Scoring Impact
| Topic | Direction | Relevance | Contribution |
|---|---|---|---|
| Consumer Protection | -against | primary | -1.00 |
| Corporate Governance | -against | secondary | -0.50 |
| Overall incident score = | -0.443 | ||
Score = avg(topic contributions) × significance (critical ×2) × confidence (0.59)× agency (negligent ×0.5)
Evidence (1 signal)
DOJ announces $600M resolution with Alibaba and AUS Merchant Services over illegal pharmaceutical sales
The Department of Justice announced that Alibaba Group and AUS Merchant Services agreed to pay a combined $600 million to resolve allegations they failed to prevent roughly 80,000 illegal sales of pharmaceuticals, controlled substances, and counterfeiting equipment conducted via Alibaba's platform between 2016 and 2024.